Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

An assessment of statin safety by muscle experts.

Thompson PD, Clarkson PM, Rosenson RS; National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel.

Am J Cardiol. 2006 Apr 17;97(8A):69C-76C. Epub 2006 Feb 9.

PMID:
16581332
2.

An assessment of statin safety by neurologists.

Brass LM, Alberts MJ, Sparks L; National Lipid Association Statin Safety Task Force Neurology Expert Panel.

Am J Cardiol. 2006 Apr 17;97(8A):86C-88C. Epub 2006 Feb 3.

PMID:
16581335
3.

An assessment by the Statin Muscle Safety Task Force: 2014 update.

Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA, The National Lipid Association's Muscle Safety Expert Panel.

J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S58-71. doi: 10.1016/j.jacl.2014.03.004.

PMID:
24793443
4.

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

McKenney JM, Davidson MH, Jacobson TA, Guyton JR; National Lipid Association Statin Safety Assessment Task Force.

Am J Cardiol. 2006 Apr 17;97(8A):89C-94C. Epub 2006 Feb 28.

PMID:
16581336
5.

An assessment of statin safety by hepatologists.

Cohen DE, Anania FA, Chalasani N; National Lipid Association Statin Safety Task Force Liver Expert Panel.

Am J Cardiol. 2006 Apr 17;97(8A):77C-81C. Epub 2006 Feb 3.

PMID:
16581333
6.

An assessment of statin safety by nephrologists.

Kasiske BL, Wanner C, O'Neill WC; National Lipid Association Statin Safety Task Force Kidney Expert Panel.

Am J Cardiol. 2006 Apr 17;97(8A):82C-85C. Epub 2006 Feb 9.

PMID:
16581334
7.

Statin safety: an overview and assessment of the data--2005.

Bays H.

Am J Cardiol. 2006 Apr 17;97(8A):6C-26C. Epub 2006 Feb 8. Review.

PMID:
16581330
8.

Muscle aches and pains from statin use. Discomfort usually resolves with a lower dose or a different statin.

[No authors listed]

Harv Heart Lett. 2012 Oct;23(2):5. No abstract available.

PMID:
23437465
9.

Statin-associated myopathy.

Hamilton-Craig I.

Med J Aust. 2001 Nov 5;175(9):486-9. Review.

PMID:
11758079
10.

Statin-associated myopathy with normal creatine kinase levels.

Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, Vladutiu GD, England JD; Scripps Mercy Clinical Research Center.

Ann Intern Med. 2002 Oct 1;137(7):581-5.

PMID:
12353945
11.

Statin myopathy.

Radcliffe KA, Campbell WW.

Curr Neurol Neurosci Rep. 2008 Jan;8(1):66-72. Review.

PMID:
18367041
12.

An assessment of statin safety.

McKenney JM.

Am J Manag Care. 2006 Oct;12(11 Suppl):S310-7.

13.

Dose-related statin myopathy: is it an issue?

Wortmann RL.

Cleve Clin J Med. 2005 Sep;72(9):751-3, 756. No abstract available.

PMID:
16193823
14.

Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation?

Koumis T, Nathan JP, Rosenberg JM, Cicero LA.

Am J Health Syst Pharm. 2004 Mar 1;61(5):515-9. Review. No abstract available.

PMID:
15018231
15.

Statin safety: lessons from new drug applications for marketed statins.

Jacobson TA.

Am J Cardiol. 2006 Apr 17;97(8A):44C-51C. Epub 2006 Feb 2.

PMID:
16581328
16.

Safety of aggressive statin therapy.

[No authors listed]

Conn Med. 2005 Jun-Jul;69(6):339-41. Review. No abstract available.

PMID:
16184860
17.

Statin-associated myopathy with normal creatine kinase levels.

Teichholz LE.

Ann Intern Med. 2003 Jun 17;138(12):1008; author reply 1008-9. No abstract available.

PMID:
12809468
18.

Myopathy associated with statin therapy.

Hilton-Jones D.

Neuromuscul Disord. 2008 Jan;18(1):97-8. Epub 2007 Sep 24. No abstract available.

PMID:
17892936
19.

Statin myopathy as a metabolic muscle disease.

Phillips PS, Haas RH.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):971-8. doi: 10.1586/14779072.6.7.971. Review.

PMID:
18666847
20.

Statin-associated myopathy and its exacerbation with exercise.

Meador BM, Huey KA.

Muscle Nerve. 2010 Oct;42(4):469-79. doi: 10.1002/mus.21817. Review.

PMID:
20878737
Items per page

Supplemental Content

Write to the Help Desk